Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TAK compared with NVS: revenue, margins and what each company keeps, and the suppliers and customers both name
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
NVS
Novartis AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
TAK
Takeda Pharmaceutical Co Ltd
vs
NVS
Novartis AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
TAK: latest quarter not drawable. NVS: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TAK, solid
NVS, dashed
TAK
Takeda Pharmaceutical Co Ltd
Change
21.06
· pre 22.00
· delayed
Mkt cap
$35.8B
NVS
Novartis AG
Change
165.00
· pre 163.36
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$303.9B
vs
Compare
Pre-market
Nov 5 '26
delayed
TAK
Takeda Pharmaceutical Co Ltd
vs
NVS
Novartis AG
21.06
pre 22.00
delayed
Price
165.00
pre 163.36
delayed
$35.8B
Mkt cap
$303.9B
Change
Change
TAK
21.06
vs
NVS
165.00
Pre-market
Nov 5 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TAK
17
NBIX
Neurocrine Biosciences
customer
EXEL
Exelixis
supplier
PTGX
Protagonist Therapeutics
supplier
DNLI
Denali Therapeutics
supplier
13 more · TAK chain
›
Shared
0
No shared counterparties.
Only NVS
21
REGN
Regeneron Pharmaceuticals
supplier
VEEV
Veeva Systems
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
PTCT
PTC Therapeutics
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
supplier
17 more · NVS chain
›